Objectives: To determine epidemiological, clinical, paraclinical and treatment characteristics of children with acyanotic congenital heart disease with left-right shunt at Children's Hospital 2 from January 1, 2024 to December 31, 2024
Method: Description of case series.
Results: There were 540 cases in the study, the proportion of females was 53.3%. The average age in months was 11 ± 41.1. The age group 1 - <6 months was 27%, accounting for the highest proportion. The majority of children came from the provinces, accounting for 66.9%. The average birth weight was 3 ± 1.69 kg. The rate of malnutrition was 42%, of which underweight malnutrition was 10.4%, wasting malnutrition was 21.8%, and stunting malnutrition was 9.8%. 13.7% of patients were hospitalized in an emergency. 4.3% of patients had a prenatal diagnosis of congenital heart disease; the most common was ventricular septal defect (45.9%). Symptoms of heart failure were 23.1%. Echocardiography showed ventricular septal defect (45.9%), patent ductus arteriosus (31.1%); 20.6% had pulmonary hypertension; On ECG, only 1.9% had arrhythmia, 57.1% had left ventricular enlargement, 23.3% had right ventricular enlargement; on X-ray, 24.8% had pulmonary artery bulge, 34.6% had increased pulmonary circulation; the average hemoglobin value was 11.8 ± 3.77 g/dl, anemia accounted for 50.6%. The average blood hematocrite value was 35.2 ± 8.7; The average hospital stay was 10 ± 25.6 days; 55.4% were treated medically waiting for intervention; 42.4% were treated medically with medication; 38.9% were treated surgically; 30.9% were treated with interventional catheterization; 87.6% improved; 2.22% were dead.
Conclusion: In 2024, 540 children with acyanotic congenital heart disease with left-right shunt were hospitalized for diagnosis and treatment at Children's Hospital. There are 2. 377 patients underwent surgery and interventional cardiology (69.8%). Treatment results included 521 (96.5%) cases of recovery/improvement/discharge/transfer due to stable, only 18 patients (3.33%) died/near mortality. This result shows more optimism than before. The rate of CHD diagnosis in the prenatal stage is still low, so screening for CHD from the prenatal stage is necessary.